ASHLEY MATKINS: Open Payments
NPI 1306535521 · MT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 59 payments from 20 companies in 2025. Trend: 2023 $41 · 2024 $1,721 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $215 |
| ABBVIE INC. | 11 | $200 |
| Novo Nordisk Inc | 8 | $146 |
| Lilly USA, LLC | 5 | $114 |
| PFIZER INC. | 3 | $74 |
| SHIELD THERAPEUTICS INC | 3 | $54 |
| SANOFI-AVENTIS U.S. LLC | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Exact Sciences Corporation | 2 | $38 |
| Medtronic, Inc. | 2 | $33 |
Products named: FARXIGA, VRAYLAR, MOUNJARO, ACCRUFER, Ozempic, AIRSUPRA, ELIQUIS, Wegovy.
Industry payments across SC — which companies pay providers there.
